These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7886295)

  • 21. [Chronic myeloid leukemia--latest aspects and practical progress in recent years].
    Griesshammer M; Heimpel H
    Med Klin (Munich); 1995 Sep; 90(9):527-31. PubMed ID: 7476731
    [No Abstract]   [Full Text] [Related]  

  • 22. [Chronic myeloid leukemia. State of the art, May 1993].
    Hehlmann R
    Schweiz Med Wochenschr; 1994 Jan; 124(1-2):37-43. PubMed ID: 8296189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Recent progress in therapy for chronic myelogenous leukemia].
    Urabe A
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1066-73. PubMed ID: 9239158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon-alpha-treated patients with chronic myelogenous leukemia show BCR/ABL-positive peripheral blood progenitor cells surviving long-term culture.
    Schultheis B; Heissig B; Pasternak G; Hörner S; Hehlmann R
    Folia Biol (Praha); 2000; 46(6):251-5. PubMed ID: 11140858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The analysis of failures in the treatment of children with chronic myelocytic leukemia in the studies of Polish pediatric leukemia/ lymphoma group].
    Chybicka A; Bogusławska-Jaworska J; Kałwak K; Turkiewicz D; Armata J; Balcerska A; Cwiklińska M; Hicke-Roberts A; Kaczmarek-Kanold M; Kołecki P; Kowalczyk J; Krauze A; Matysiak M; Płoszyńska A; Rokicka-Milewska R; Sońta-Jakimczyk D; Sikorska-Fic B; Wiśniewska-Slusarz H; Wysocki M; Wachowiak J
    Wiad Lek; 1998; 51 Suppl 4():33-9. PubMed ID: 10731941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prophylactic use of interferon alfa after bone marrow transplantation for patients with chronic myelogenous leukemia at high risk of relapse: a pilot study. The Chronic Leukemia Working Party of the EBMT.
    Niederwieser D; Arcese W; Bandini G; Schwaighofer H; Thaler J; Bosi A; Di Bartolomeo P; Alessandrino EP; Urban C; Gratwohl A
    Semin Hematol; 1993 Jul; 30(3 Suppl 3):40-3. PubMed ID: 8235706
    [No Abstract]   [Full Text] [Related]  

  • 27. Chemotherapy and bone marrow transplantation in the treatment of chronic myelogenous leukemia.
    Kantarjian HM; Talpaz M
    Semin Oncol; 1994 Dec; 21(6 Suppl 14):8-13. PubMed ID: 7992099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chronic myeloid leukemia. Current strategies in diagnosis, therapy and follow-up].
    Hochhaus A; Hehlmann R
    Internist (Berl); 1996 Oct; 37(10):1013-21. PubMed ID: 9019445
    [No Abstract]   [Full Text] [Related]  

  • 29. [Changing concept of conventional therapy in chronic myelogenous leukemia].
    Ueda R
    Rinsho Ketsueki; 2000 Apr; 41(4):268-71. PubMed ID: 10846452
    [No Abstract]   [Full Text] [Related]  

  • 30. Chronic myelogenous leukemia clinical practice guidelines in oncology.
    O'Brien S;
    J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S14-28. PubMed ID: 19795573
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of chronic myeloid leukemia using alpha-interferon and hydroxyurea. Study of 30 cases].
    Nese M; de Bellis R; Urtiarte R; Di Landro J
    Sangre (Barc); 1994 Jun; 39(3):183-6. PubMed ID: 7940047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
    Ohnishi K; Minami S; Ueda T; Nishimura M; Tsubaki K; Takemoto Y; Takeshita A; Sao H; Kageyama S; Ueda R; Ohno R
    Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chronic myeloid leukemia].
    Hehlmann R
    Ther Umsch; 1996 Feb; 53(2):82-7. PubMed ID: 8629268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The natural history of chronic myelogenous leukemia in the interferon era.
    Giralt S; Kantarjian H; Talpaz M
    Semin Hematol; 1995 Apr; 32(2):152-8. PubMed ID: 7652582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia.
    Kantarjian HM; Kurzrock R; Talpaz M
    Hematol Oncol Clin North Am; 1990 Apr; 4(2):389-404. PubMed ID: 2182598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autologous transplantation therapy for chronic myelogenous leukemia.
    Bhatia R; Verfaillie CM; Miller JS; McGlave PB
    Blood; 1997 Apr; 89(8):2623-34. PubMed ID: 9108379
    [No Abstract]   [Full Text] [Related]  

  • 37. Chronic myelogenous leukemia: does interferon alpha prolong life?
    Hehlmann R
    Leukemia; 1996 Feb; 10(2):193-6. PubMed ID: 8637225
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical study of chronic myelogenous leukemia].
    Shibata A
    Nihon Naika Gakkai Zasshi; 1993 Sep; 82(9):1318-30. PubMed ID: 8245626
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of myelogenous leukemia: current status and investigational options.
    Kantarjian HM; O'Brien S; Anderlini P; Talpaz M
    Blood; 1996 Apr; 87(8):3069-81. PubMed ID: 8605319
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of chronic myeloid leukemia].
    Guilhot F
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):151-4. PubMed ID: 7687766
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.